BRIEF-Bayer To Produce CureVac COVID-19 Vaccine At Wuppertal Site

BRIEF-Bayer To Produce CureVac COVID-19 Vaccine At Wuppertal Site
Representative image Image Credit: ANI

* BAYER SAYS WUPPERTAL IS IMPORTANT SITE FOR PRODUCING CUREVAC COVID-19 VACCINE

* BAYER SAYS CUREVAC COVID-19 VACCINE WILL BE PRODUCED IN WUPPERTAL * CUREVAC SAYS LOOKING CLOSELY AT BRAZIL VARIANT

* CUREVAC SAYS DON'T KNOW YET HOW LONG MEMORY EFFECT OF COVID-19 VACCINE WILL LAST * CUREVAC SAYS IMPORTANT TO HAVE ADDITIONAL PRODUCTION CAPACITIES TO PRODUCE VACCINES AGAINST NEW VARIANTS

* PREMIER OF GERMAN STATE OF NRW SAYS HAVE HALVED TIME NEEDED TO APPROVE VACCINE PRODUCTION * GERMAN HEALTH MINISTER SAYS AHEAD OF VACCINE SUMMIT: GERMAN AGE RECOMMENDATION FOR ASTRAZENECA VACCINE COULD CHANGE ONCE WE HAVE MORE INFO Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.